This study is designed to perform a explorative search of the transcriptome to detect new circulating diagnostic sensitive and specific biomarkers in patients with Barrett's esophagus or esophageal adenocarcinoma.
Barrett's Esophagus with length > 3cm OR esophageal adenocarcinoma histologically proven
Adequate mental faculty, allowing to understand the proposed treatment protocol and provide informed consent
Age over 18 years
No other concurrent malignant disease
Pregnancy or breast feeding
Active bacterial, viral or fungal infection
Parenchymal liver disease (any stage cirrhosis)
High risk of bleeding during biopsy (anticoagulants, esophageal varices)
University Hospital, Ghent
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Collaborator